Emcure Pharmaceuticals Limited

Pharmaceutical company manufacturing tablets, capsules, and injectables with accredited facilities and global market reach.

1981 | Pune, Maharashtra (India) | Active
Last Updated:

Emcure Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 250.00 Cr
  • Paid Up Capital ₹ 189.43 Cr
  • Company Age 43 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1,383.55 Cr
  • Satisfied Charges ₹ 7,023.21 Cr
  • Revenue Growth -8.17%
  • Profit Growth -64.18%
  • Ebitda -44.82%
  • Net Worth 7.55%
  • Total Assets 6.77%

About Emcure Pharmaceuticals

Emcure Pharmaceuticals Limited (EPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 16 April 1981 and has a history of 43 years and ten months. Its registered office is in Pune, Maharashtra, India.

The Corporate was formerly known as Emcure Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 250.00 Cr and a paid-up capital of Rs 189.43 Cr.

The company currently has active open charges totaling ₹1,383.55 Cr. The company has closed loans amounting to ₹7,023.21 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Emcure Pharmaceuticals Limited India are Satish Mehta as Ceo, Tajuddin Shaikh as Cfo, and Chetan Sharma as Company Secretary. Mukund Gurjar, Sunil Mehta, Satish Mehta, and Seven other members serve as directors at the Company.

Company Details

  • Location

    Pune, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    emcure.co.in

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24231PN1981PLC024251

  • Company No.

    024251

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    16 Apr 1981

  • Date of AGM

    05 Jun 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Pune

Industry

Pharma

What products or services does Emcure Pharmaceuticals Limited offer?

Emcure Pharmaceuticals Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Anti Inflammatory Drugs, Pharma Ingredients & Raw Materials, Antipyretic and Analgesic API, Pharmaceutical Medicine, Torex Cough Syrup, Infusion Syringes & Supplies, Syringes, Cosmetics, Hair & Beauty Products.

Who are the key members and board of directors at Emcure Pharmaceuticals?

Executive Team (3)

NameDesignationAppointment DateStatus
Satish Mehta Country flag representing In Managing Director16-Apr-1981Current
Tajuddin Shaikh Country flag representing In CFO16-Apr-2021Current
Chetan Sharma Company Secretary26-Jun-2023Current

Board Members (9)

NameDesignationAppointment DateStatus
Vidya Yeravdekar Country flag representing In Director 16-Apr-2021Current
Shailesh Ayyangar Country flag representing Io Director 16-Apr-2021Current
Namita Thapar Country flag representing In Whole-Time Director 28-Jul-2014Current
Mukund Gurjar Country flag representing In Whole-Time Director 23-Jul-2001Current
Berjis Desai Country flag representing In Director 03-Apr-1997Current
Sunil Mehta Country flag representing In Whole-Time Director 05-Jun-2013Current

Financial Performance of Emcure Pharmaceuticals.

Emcure Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.17% decrease. The company also saw a substantial fall in profitability, with a 64.18% decrease in profit. The company's net worth moved up by a moderate rise of 7.55%.

Emcure Pharmaceuticals revenue growth over time
Emcure Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-8.17%
Revenue from Operations
-8.27%
Total Assets
6.77%
Profit or Loss
-64.18%
Net Worth
7.55%
EBITDA
-44.82%

What is the Ownership and Shareholding Structure of Emcure Pharmaceuticals?

In 2023, Emcure Pharmaceuticals had a promoter holding of 48.05% and a public holding of 51.94%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹1,383.55 Cr

Satisfied Charges

₹7,023.21 Cr

Charges Breakdown by Lending Institutions

  • Others : 970.00 Cr
  • Axis Bank Limited : 411.48 Cr
  • Hdfc Bank Limited : 2.06 Cr

Latest Charge Details

DateLenderAmountStatus
15 May 2024Others₹100.00 CrOpen
04 May 2023Others₹175.00 CrOpen
25 Mar 2022Others₹275.00 CrOpen
07 Sep 2021Others₹250.00 CrOpen
23 Aug 2021Axis Bank Limited₹2.21 CrOpen

How Many Employees Work at Emcure Pharmaceuticals?

Emcure Pharmaceuticals has a workforce of 6414 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Emcure Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Emcure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emcure Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Emcure Pharmaceuticals

Recent activity within the organization

  • Charges

    A charge registered on 24 Dec 2019 via Charge ID 100311749 with Others was fully satisfied on 28 Jan 2025.

  • Charges

    A charge registered on 20 Dec 2023 via Charge ID 100843954 with Tata Capital Financial Services Limited was fully satisfied on 22 Jan 2025.

  • Charges

    A charge registered on 22 Jun 2021 via Charge ID 100458389 with Tata Capital Financial Services Limited was fully satisfied on 22 Jan 2025.

  • Charges

    A charge registered on 27 Sep 2019 via Charge ID 100293763 with Tata Capital Financial Services Limited was fully satisfied on 22 Jan 2025.

  • Charges

    A charge registered on 27 Jun 2022 via Charge ID 100590827 with Others was fully satisfied on 15 Jan 2025.

  • Charges

    A charge registered on 31 Dec 2019 via Charge ID 100312899 with Hdfc Bank Limited was fully satisfied on 10 Dec 2024.

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Emcure Pharmaceuticals Limited?

    Emcure Pharmaceuticals Limited was incorporated on 16 Apr 1981.

  • What is authorized share capital and paid-up capital of Emcure Pharmaceuticals Limited?

    The authorized share capital of Emcure Pharmaceuticals Limited is ₹ 250.00 Cr and paid-up capital is ₹ 189.43 Cr.

  • Who are the current board members & directors of Emcure Pharmaceuticals Limited?

    Currently 13 directors are associated with Emcure Pharmaceuticals Limited.

    • Mukund Keshao Gurjar
    • Sunil Rajanikant Mehta
    • Satish Ramanlal Mehta
    • Berjis Minoo Desai
    • Shailesh Kripalu Ayyangar
    • Samit Satish Mehta
    • Palamadai Sundararajan Jayakumar
    • Vidya Rajiv Yeravdekar
    • Namita Vikas Thapar
    • Vijay Keshav Gokhale
    • Satish Ramanlal Mehta
    • Tajuddin Sabir Shaikh
    • Chetan Rajendra Sharma

  • What is the registered address of Emcure Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Emcure Pharmaceuticals Limited is Plot No. P-1 P-2 It-Bt Park Phase-Ii, M.I.D.C. India, Pune City, Maharashtra, 411057.

  • What is the corporate identification number (CIN) and company number of Emcure Pharmaceuticals Limited?

    The corporate identification number (CIN) of Emcure Pharmaceuticals Limited is L24231PN1981PLC024251 and the company number is 024251 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Emcure Pharmaceuticals Limited?

    The Official website of Emcure Pharmaceuticals Limited is https://www.emcure.co.in

  • What has been the recent revenue trend for Emcure Pharmaceuticals Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Emcure Pharmaceuticals Limited has fallen by -8.17%.

  • How many employees does Emcure Pharmaceuticals Limited currently have?

    As Per 2023 financial reports, 6414 employees are currently employed by Emcure Pharmaceuticals Limited.

  • What change has been observed in the net worth of Emcure Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Emcure Pharmaceuticals Limited has experienced an upsurge of 7.55%.

  • What are the total open charges for Emcure Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Emcure Pharmaceuticals Limited amount to ₹ 1,383.55 Cr.

  • When was the last Balance Sheet of Emcure Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Emcure Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on API Manufacturers